All the latest news and updates about GLP-1 Drugs
Whilst showing promise in cancer therapies, lead-212-based alpha emitters are hard to commercially supply.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.